Johnson & Johnson invests in Jacksonville
Johnson & Johnson has announced an investment of more than $1 billion in Jacksonville, Fla., to strengthen its vision operations by scaling the U.S.-based manufacturing, packaging and distribution capabilities. The investment includes construction of a new, state-of-the-art distribution facility, alongside advanced manufacturing and packaging technologies to expand capacity and meet growing demand for the company’s Acuvue-brand contact lenses, according to the announcement. Johnson & Johnson said it manufactures more than 1.7 billion Acuvue contact lenses annually for U.S. patients.
The transaction is part of the company’s previously announced $55 billion U.S. investment in manufacturing, research and development, and technology through early 2029. Construction of the new facility is underway with the goal of being fully operational in 2028.
“This investment reinforces our long-standing conviction that advanced manufacturing in the United States is essential to delivering innovative, high quality healthcare solutions to patients at home and around the world,” said Joaquin Duato, chairman and CEO of Johnson & Johnson. “By further strengthening our vision operations in Jacksonville with next-generation manufacturing, packaging and distribution capabilities, we are enhancing the resilience of our U.S. supply chain while helping more people see better and live better. This commitment reflects the confidence we have in our people, our technology, and our more than 40-year legacy of advancing eye health globally.”
The investment builds on the company’s $6 billion annual economic impact in Florida and supports the continued growth of its Jacksonville operations, strengthening opportunities for the 3,500 employees based in the area while reinforcing the regional economy, the company said.
“Johnson & Johnson’s commitment is a strong vote of confidence in Jacksonville, our workforce, and our future,” said Jacksonville mayor Donna Deegan. “Jacksonville continues to lead in advanced manufacturing and life sciences innovation. This expansion strengthens our high-tech footprint while creating quality jobs and long-term opportunities for our community.”
